COMPANY
Apeximmune Therapeutics Inc.
Apeximmune Therapeutics is a new generation of therapeutic antibodies that harness the power of the immune system to treat cancers. From company website Source · Oct 12, 2026
NIH awards 1
- NIH award 1R43CA278134-01A1 FY2023: $399,618 awarded for that fiscal year; activity R43 (SBIR); PI LEE, LI-FEN; recipient as written: APEXIMMUNE THERAPEUTICS INC., Burlingame, CA. PLA2G2D Antibodies for Cancer Immuno source ↗